Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada flag Canada · Delayed Price · Currency is CAD
0.1150
-0.0050 (-4.17%)
At close: Mar 20, 2026

Ventripoint Diagnostics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.210.10.050.07-0.04
Revenue Growth (YoY)
52.21%93.51%-27.85%---55.55%
Cost of Revenue
--0.010.01-0.01
Gross Profit
0.210.10.040.06-0.03
Selling, General & Admin
3.413.933.893.923.251.64
Research & Development
0.480.971.081.050.460.27
Other Operating Expenses
----0.010.02
Total Operating Expenses
3.894.94.974.973.721.94
Operating Income
-3.68-4.8-4.93-4.91-3.72-1.91
Interest Income
0.430.18-0.010.01-0.030.22
Interest Expense
-0.23-----
Other Non-Operating Income (Expense)
0.010.010.060.11-0.20.28
Total Non-Operating Income (Expense)
-0.020.190.050.12-0.230.5
Pretax Income
-3.7-4.62-4.88-4.79-3.94-1.41
Provision for Income Taxes
--0.08----
Net Income
-3.94-4.92-4.87-4.87-3.88-1.85
Net Income to Common
-3.94-4.92-4.87-4.87-3.88-1.85
Shares Outstanding (Basic)
16415815715613675
Shares Outstanding (Diluted)
16415815715613675
Shares Change (YoY)
4.24%0.93%0.53%14.62%82.64%17.58%
EPS (Basic)
-0.03-0.03-0.03-0.03-0.03-0.02
EPS (Diluted)
-0.03-0.03-0.03-0.03-0.03-0.02
Free Cash Flow
-1.68-3.39-3.8-4.14-3.15-1.1
Free Cash Flow Per Share
-0.01-0.02-0.02-0.03-0.02-0.01
Gross Margin
100.00%100.00%86.28%84.80%-72.94%
Operating Margin
-1770.33%-5045.41%-10024.80%-7203.96%--5302.63%
Profit Margin
-1443.39%-5169.14%-9905.73%-7148.33%--5138.34%
FCF Margin
-806.42%-3557.98%-7734.16%-6068.54%--3065.54%
EBITDA
-3.62-4.74-4.86-4.86-3.67-1.85
EBITDA Margin
-1740.85%-4979.35%-9889.25%-7129.29%--5150.09%
EBIT
-3.68-4.8-4.93-4.91-3.72-1.91
EBIT Margin
-1770.33%-5045.41%-10024.80%-7203.96%--5302.63%
Effective Tax Rate
-1.81%0.00%0.00%0.00%0.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.